Anti-EGFR Antibody (Cetuximab) Enhances Killing of Chordoma Cells Through ADCC and Combinatorial Treatment with Cetuximab and IL15/IL15r Superagonist (N-803) Further Enhances Cytotoxicity. Here, IL15 is linked to chordoma.